The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Aug. 8, 12:38 PM

Slide #12. Brickell Biotech, Inc. (NASDAQ:BBI) 1 for 45 Reverse Split

Announced: 7/1/2022
Stock Split: 1 for 45
Record Date: 7/1/2022
Pay Date: 7/5/2022
BBI Optionable?: No

Brickell Biotech is a clinical-stage pharmaceutical company focused on the development of prescription therapeutics for the treatment of debilitating skin diseases with a focus on its main asset for the treatment of hyperhidrosis. Co.'s investigational product candidate, sofpironium bromide, is a chemical entity that belongs to a class of medications called anticholinergics. Anticholinergics block the action of acetylcholine, a chemical that transmits signals within the nervous system that are responsible for a range of bodily functions, including activation of the sweat glands. Co. is developing sofpironium bromide in the U.S. for the treatment of primary axillary hyperhidrosis.
BBI Detailed Information Page & Split History »

Company Name: 
Brickell Biotech Inc
Website: 
www.ir.brickellbio.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding BBI: 
3
Total Market Value Held by ETFs: 
$42.30M
Total Market Capitalization: 
$11.00M
% of Market Cap. Held by ETFs: 
384.53%

Open the BBI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree BBI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.50 out of 4)
51st percentile
(ranked higher than approx. 51% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.